Premium
This is an archive article published on August 17, 2012

Doctor-pharma nexus: ‘Govt mulling to introduce new code’

The government is planning to introduce 'Uniform Code of Pharmaceutical Marketing Practices' to deal with the alleged nexus between doctors and drug companies.

The government is planning to introduce ‘Uniform Code of Pharmaceutical Marketing Practices’ to deal with the alleged nexus between doctors and drug companies,the Lok Sabha was informed today.

Health Minister Ghulam Nabi Azad,in his written reply to a question in the House,said his Ministry had received 702 complaints against doctors regarding their alleged nexus with drug manufacturers.

The complaints have been referred to the Medical Council of India (MCI) for action,he said.

“The government proposes to make the existing provisions more stringent through ‘Uniform Code of Pharmaceutical Marketing Practices’ (UCPMP) proposed by the Department of Pharmaceuticals,” Azad said in his written reply.

He said a total of 702 such complaints against doctors have been received by the MCI in 2011-12,of which 343 have been referred to state Medical Councils/governments,while registration of three doctors has been temporarily suspended and one doctor has been given a warning and 168 cases are under consideration of the MCI.

In 2010-11,Azad said,a total of 824 complaints were received and 468 were referred to State Medical Councils/ governments while registration of 10 doctors was suspended temporarily and warnings issued to four doctors.

Similarly,769 complaints against doctors were received by MCI in 2009-10 and registration of 16 doctors was suspended temporarily and warnings issued to six doctors,while remaining 254 cases were referred to states.

Story continues below this ad

Azad said MCI takes action in such complaints as per provisions of the Indian Medical Council (Professional conduct,Etiquette and Ethics) Regulations,2002.

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Loading Taboola...
Advertisement